Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
(PubMed) Xu S, Huang H, Qian J, et al
Its cell-penetrating properties allow it to enter cells without transfection or vector delivery, where it directly engages the p53 TAD2 domain to disrupt the FOXO4-p53 complex
Retinol boosts collagen production, accelerates cell turnover, and reduces hyperpigmentation
A separate product, semaglutide subcutaneous injection (Wegovy), is indicated as an adjunct to lifestyle modifications for weight loss and chronic weight management in obese (BMI 30 kg/m2 or greater) or overweight adults (BMI 27 kg/m2 or greater) with at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
A related medication containing tirzepatide, marketed under the brand name Zepbound, is FDA-approved for weight management
